For example, ZNF35 was found to differentiate the prognoses of COAD patients in a validation on independent test sets [41], and the transcription factor SATB2 was identified as a highly specific marker in colorectal adenocarcinoma when used in conjunction with CK20 [42]. The gene discussed is SATB2; the disease is colon adenocarcinoma.